Dirk Pamperin
Directeur/Bestuurslid bij SYNTHAVERSE S.A.
Actieve functies van Dirk Pamperin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SYNTHAVERSE S.A. | Directeur/Bestuurslid | 01-01-2020 | - |
APOGEPHA Arzneimittel GmbH
 APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Algemeen Directeur | 01-01-2018 | - |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2012 | 01-01-2018 |
Loopbaan van Dirk Pamperin
Eerdere bekende functies van Dirk Pamperin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Synthon BV
 Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Hoofd Techniek/Wetenschap/O&O | 01-01-2005 | 01-01-2012 |
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Corporate Officer/Principal | 01-01-1998 | 01-01-2005 |
Opleiding van Dirk Pamperin
| Technische Universität Braunschweig | Undergraduate Degree |
| Universität Stuttgart | Doctorate Degree |
Statistieken
Internationaal
| Duitsland | 4 |
| Polen | 2 |
| Nederland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SYNTHAVERSE S.A. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Health Services |
Synthon BV
Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Health Technology |
- Beurs
- Insiders
- Dirk Pamperin
- Ervaring
